Anzeige
Mehr »
Login
Montag, 20.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Aktienchance des Jahres! Ihre Chance auf explosive Gewinne!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
228 Leser
Artikel bewerten:
(1)

Italian Food and Beverage Corp: IFBC Accelerates Company Growth

Finanznachrichten News

PLAINVIEW, NY / ACCESSWIRE / October 11, 2022 / Italian Food & Beverage Corp. (OTC:IFBC): Further to its press release of September 12, 2022, is pleased to announce that it has expanded its operations into additional Western Beef locations, broadening its presence within these stores. IFBC products are accorded the highest and best visibility and are accompanied by eye-catching marketing and sales displays directly in front of the cash out stations.

Stock Market Manager, Inc., Tuesday, October 11, 2022, Press release picture

In a very short time, this prized relationship with Western Beef has allowed the Company to accelerate its growth, enlarge its customer base, increase its profits, and deepen its penetration into the lucrative energy drink market. IFBC's strategic product placement within the Western Beef chain, has resulted in a sizable uptick in repeat customer sales, as well as the acquisition of new customers from the US and elsewhere. IFBC's exposure to Western Beef's international customer base bodes well for IFBC as it happened during its international launch adding a distributor in Switzerland while continues its expansion in Italy where IFBC has positioned itself in several retail locations, including supermarkets and well-placed vending machines.

Dino Luzzi, Chairman and CEO of IFBC, states "we never lost sight of our growth strategy, we have increased sales profitability's and exposure for our product and enhanced our board of director with a food broker with over 25 years of experience, targeting additional high-profile retail chains, our food broker whose clients include, among many others, Polly-O, Gioioso, and Mike's Honey, has introduced IFBC to major food retailers validating our plans to expand our footprint in the energy drink market. We doubled our sales in the last two quarters and our presence in Western Beef, and we are very excited about the company future."

CEO interview by Sequire

Forward Looking Statements

This release contains "forward-looking statements" and information provided by Italian Food & Beverage Corp. such as online, printed documents, publications or information available via its website. It may contain certain forward-looking statements that involve risks, uncertainties, assumptions and other factors, which, if they do not materialize or prove correct, could cause the Company's results to differ materially from historical results, or those expressed or implied by such forward-looking statements. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements. These statements may also include plans, strategies and objectives of management for future operations; any statements regarding proposed new products, services or developments; any statements regarding future economic conditions or performance; statements of belief; and any statements of assumptions underlying any of the foregoing. There can be no
assurance that the negotiations being considered by the letter of intent will be completed.

CONTACT

Dino Luzzi
CEO
516-637-5937
info@ifbcorp.com

SOURCE: Italian Food and Beverage Corp



View source version on accesswire.com:
https://www.accesswire.com/719661/IFBC-Accelerates-Company-Growth

© 2022 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.